Company: SCLXW
Filing Date: 2025-07-23
Form Type: 424B3
Source: 0001193125-25-163077
Chunk: 224

Company: Scilex Holding Co
Filing Date: 2025-07-23
Form: 424B3
Chunk 224
---
 2hereof, and for Scilex to repurchase the Subject Warrants. 1. Option to Purchase Subject Warrants. (a) Grant of Option.Subject to and upon the terms and conditions set forth in this Agreement, Oramed hereby grants to Purchaser an exclusive, irrevocable option (the “ Option”) to purchase the Initial Subject Warrants (as defined below) and the Final Subject Warrants (as defined below), at such times and in such amounts as set forth in this Agreement. The Option shall expire automatically and without the requirement of any further action by any Party at 12:01 am eastern on December 16, 2025, subject to Oramed’s Termination Right (as defined below) pursuant to Section 8(f). (b) Payment for Option.In consideration of the grant of the Option, Purchaser shall pay to Oramed an aggregate option purchase price of $1,500,000.00 (the “ Option Fee”), to be paid as

***Certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) information that the Registrant treats as private or confidential. Such omitted information is indicated by brackets (“[...***...]”) in this exhibit. ***

follows and in each case by wire transfer of immediately available funds
to an account or accounts designated by Oramed not less than three (3) Business Days prior to the applicable payment date:

(i) on or before August 8, 2025 (the “”), Purchaser shall pay $750,000.00 of
the Option Fee to Oramed (the delivery of such payment by Purchaser, the “” and such payment the “”); and

(ii) on or before December 16, 2025 (the “” and together with the First Option
Payment Date, the “” and each an “”), Purchaser shall pay to Oramed $750,000.00 of the Option Fee (the delivery of such payment by Purchaser, the
“” and together with the First Option Closing, the “” and each an “” and such payment at the Second Option Closing, the “” and together with the First Option Closing Payment, the “” and each an “”).

(c) . Not later than the First Option Payment Date, Purchaser shall pay to
Proskauer Rose LLP (“”) counsel for Oramed, by wire transfer of immediately available funds to an account or accounts